ArticleJCO clinical cancer informatics2025
Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With Radiotherapy.
Keyur D Shah, Beow Y Yeap, Hoyeon Lee, Zainab O Soetan, Maryam Moteabbed, Stacey Muise, Jessica Cowan, Kyla Remillard, Brenda Silvia, Nancy P Mendenhall and 7 more
Abstract readMulticenter Study
In one paragraphArticle in JCO clinical cancer informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Keyur D ShahDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0002-0886-655X Beow Y YeapDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Hoyeon LeeDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0002-1165-1509 Zainab O SoetanDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0009-0008-7967-4054 Maryam MoteabbedDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Stacey MuiseDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Jessica CowanDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Kyla RemillardDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0002-9275-0209 Brenda SilviaDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Nancy P MendenhallDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL.
Edward SoffenDepartment of Radiation Oncology, Princeton Radiation Oncology, Monroe, NJ.
Mark V MishraDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD.ORCID 0000-0002-2588-1575 Sophia C KamranDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0001-9283-6515 David T MiyamotoDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Harald PaganettiDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Jason A EfstathiouDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0003-0996-0350 Ibrahim ChamseddineDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0002-7005-8692 Funding
Project 3: Enhanced Sensitivity of Tumors to Proton Beam Therapy: Mechanisms and Biomarkers.P01CA261669 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI TITT, UWE · 2021 to 2025
$14.0MBlood-based monitoring of bladder-sparing trimodality therapy for muscle-invasive bladder cancerR01CA259007 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MIYAMOTO, DAVID T. · 2022 to 2025
$3.0MPROTON THERAPY RESEARCH AND TREATMENT CENTERC06CA059267 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI GOITEIN, MICHAEL · 1992 to 1995
–NCI NIH HHS C06 CA059267NCI NIH HHS P01 CA261669NCI NIH HHS R01 CA259007
6 · The paper itselfAbstract
purposeTo aid personalized treatment selection, we developed a predictive model for acute rectal toxicity in patients with prostate cancer undergoing radiotherapy with photons and protons. MATERIALS AND
methodsWe analyzed a prospective multi-institutional cohort of 278 patients treated from 2012 to 2023 across 10 centers. Dosimetric and nondosimetric variables were collected, and key predictors were identified using purposeful feature selection. The cohort was split into discovery (n = 227) and validation (n = 51) data sets. The dose along the rectum surface was transformed into a two-dimensional surface, and dose-area histograms (DAHs) were quantified. A convolutional neural network (CNN) was developed to extract dosimetric features from the DAH and integrate them with nondosimetric predictors. Model performance was benchmarked against logistic regression (LR) using the AUC.
resultsKey predictors included rectum length, race, age, and hydrogel spacer use. The CNN model demonstrated stability in the discovery data set (AUC = 0.81 ± 0.11) and outperformed LR in the validation data set (AUC = 0.81
conclusionOur novel approach effectively predicts rectal toxicity across photon and proton subsets, demonstrating the utility of integrating dosimetric and nondosimetric features. The model's strong performance across modalities suggests potential for guiding treatment decisions, warranting prospective validation.
Indexed as
Prostatic NeoplasmsRadiation InjuriesRectumAgedHumansMaleMiddle AgedNeural Networks, ComputerProspective StudiesProton TherapyRadiotherapy DosageRadiotherapy Planning, Computer-Assisted
Identifiers
PMID40106736
PMCPMC11938327
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390